Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction. Montelukast/Salmeterol Exercise Study Group

Montelukast, a leukotriene receptor antagonist, and salmeterol, a long-acting beta(2)-receptor agonist, each have demonstrated benefits in the treatment of exercise-induced bronchoconstriction (EIB) in short-term studies. Direct comparisons between these agents in long-term studies are limited. We s...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of allergy and clinical immunology 1999-09, Vol.104 (3 Pt 1), p.547-553
Hauptverfasser:	Villaran, C, O'Neill, S J, Helbling, A, van Noord, J A, Lee, T H, Chuchalin, A G, Langley, S J, Gunawardena, K A, Suskovic, S, Laurenzi, M, Jasan, J, Menten, J, Leff, J A
Format:	Artikel
Sprache:	eng
Schlagworte:	Acetates - therapeutic use Adolescent Adult Albuterol - analogs & derivatives Albuterol - therapeutic use Asthma, Exercise-Induced - drug therapy Bronchial Diseases - drug therapy Bronchodilator Agents - therapeutic use Constriction, Pathologic Double-Blind Method Female Humans Male Middle Aged Quinolines - therapeutic use Salmeterol Xinafoate Single-Blind Method
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!